Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2007, Article ID 53549, 4 pages
http://dx.doi.org/10.1155/2007/53549
Case Report

Successful Salvage and Long-Term Survival after Recurrent Malignant Rhabdoid Tumor

1Department of Orthopaedic Surgery, Medical School, University of Minnesota, Minneapolis, MN 55454, USA
2Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, MN 55454, USA

Received 9 January 2007; Revised 21 February 2007; Accepted 31 May 2007

Academic Editor: Alessandro Gronchi

Copyright © 2007 Ryan Horazdovsky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Beckwith and N. F. Palmer, “Histopathology and prognosis of Wilms tumor: results from the first national Wilms' tumor study,” Cancer, vol. 41, no. 5, pp. 1937–1948, 1978. View at Publisher · View at Google Scholar
  2. B. M. D. Brennan, A. B. M. Foot, C. Stiller et al., “Where to next with extracranial rhabdoid tumours in children,” European Journal of Cancer, vol. 40, no. 4, pp. 624–626, 2004. View at Publisher · View at Google Scholar
  3. A. Fabre, B. Eyden, and H. H. Ali, “Soft-tissue extrarenal rhabdoid tumor with a unique long-term survival,” Ultrastructural Pathology, vol. 28, no. 1, pp. 49–52, 2004. View at Google Scholar
  4. D. M. Parham, D. A. Weeks, and J. B. Beckwith, “The clinicopathologic spectrum of putative extrarenal rhabdoid tumors: an analysis of 42 cases studied with immunohistochemistry or electron microscopy,” The American Journal of Surgical Pathology, vol. 18, no. 10, pp. 1010–1029, 1994. View at Google Scholar
  5. D. M. Parham, “An inaccuracy,” The American Journal of Surgical Pathology, vol. 19, no. 4, pp. 488–489, 1995. View at Publisher · View at Google Scholar
  6. S. Gururangan, L. C. Bowman, D. M. Parham et al., “Primary extracranial rhabdoid tumors: clinicopathologic features and response to ifosfamide,” Cancer, vol. 71, no. 8, pp. 2653–2659, 1993. View at Publisher · View at Google Scholar
  7. R. Kodet, W. A. Newton Jr., N. Sachs et al., “Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the intergroup rhabdomyosarcoma study,” Human Pathology, vol. 22, no. 7, pp. 674–684, 1991. View at Publisher · View at Google Scholar
  8. C. Sotelo-Avila, F. Gonzalez-Crussi, D. deMello et al., “Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients,” Seminars in Diagnostic Pathology, vol. 3, no. 2, pp. 151–163, 1986. View at Google Scholar
  9. H. Shiratsuchi, T. Saito, A. Sakamoto et al., “Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation,” Modern Pathology, vol. 15, no. 2, pp. 146–153, 2002. View at Publisher · View at Google Scholar
  10. J. C. Fanburg-Smith, M. Hengge, U. R. Hengge, J. S. C. Smith Jr., and M. Miettinen, “Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases,” Annals of Diagnostic Pathology, vol. 2, no. 6, pp. 351–362, 1998. View at Publisher · View at Google Scholar
  11. A. C. Hoot, P. Russo, A. R. Judkins, E. J. Perlman, and J. A. Biegel, “Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors,” The American Journal of Surgical Pathology, vol. 28, no. 11, pp. 1485–1491, 2004. View at Publisher · View at Google Scholar
  12. J. A. Biegel, G. Kalpana, E. S. Knudsen et al., “The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors,” Cancer Research, vol. 62, no. 1, pp. 323–328, 2002. View at Google Scholar
  13. C. W. M. Roberts and S. H. Orkin, “The SWI/SNF complex—chromatin and cancer,” Nature Reviews Cancer, vol. 4, no. 2, pp. 133–142, 2004. View at Google Scholar
  14. J. Simons, I. Teshima, M. Zielenska et al., “Analysis of chromosome 22q as an aid to the diagnosis of rhabdoid tumor: a case report,” The American Journal of Surgical Pathology, vol. 23, no. 8, pp. 982–988, 1999. View at Publisher · View at Google Scholar
  15. B. L. Betz, M. W. Strobeck, D. N. Reisman, E. S. Knudsen, and B. E. Weissman, “Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB,” Oncogene, vol. 21, no. 34, pp. 5193–5203, 2002. View at Publisher · View at Google Scholar
  16. B. S. Reincke, G. B. Rosson, B. W. Oswald, and C. F. Wright, “INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells,” Journal of Cellular Physiology, vol. 194, no. 3, pp. 303–313, 2003. View at Publisher · View at Google Scholar
  17. I. Versteege, S. Medjkane, D. Rouillard, and O. Delattre, “A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle,” Oncogene, vol. 21, no. 42, pp. 6403–6412, 2002. View at Publisher · View at Google Scholar
  18. R. G. J. Vries, V. Bezrookove, L. M. P. Zuijderduijn et al., “Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint,” Genes and Development, vol. 19, no. 6, pp. 665–670, 2005. View at Publisher · View at Google Scholar
  19. F. Bourdeaut, P. Fréneaux, B. Thuille et al., “hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities,” Journal of Pathology, vol. 211, no. 3, pp. 323–330, 2007. View at Publisher · View at Google Scholar
  20. M. C. Frühwald, M. Hasselblatt, S. Wirth et al., “Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome,” Pediatric Blood & Cancer, vol. 47, no. 3, pp. 273–278, 2006. View at Publisher · View at Google Scholar
  21. B. Behring, W. Brück, H. H. Goebel et al., “Immunohistochemistry of primary central nervous system malignant rhabdoid tumors: report of five cases and review of the literature,” Acta Neuropathologica, vol. 91, no. 6, pp. 578–586, 1996. View at Publisher · View at Google Scholar
  22. T. Yuri, N. Danbara, N. Shikata et al., “Malignant rhabdoid tumor of the liver: case report and literature review,” Pathology International, vol. 54, no. 8, pp. 623–629, 2004. View at Publisher · View at Google Scholar
  23. S. J. Hunt and W. D. Anderson, “Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity,” American Journal of Clinical Pathology, vol. 94, no. 5, pp. 645–648, 1990. View at Google Scholar